InsidersTradesSigma
Track the PROVECTUS BIOPHARMACEUTICALS, INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €24m. The latest transaction was filed on 14 August 2024 (C). Among the most active insiders: Morris Jeffrey Allen. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
PROVECTUS BIOPHARMACEUTICALS, INC. 是一家生物制药公司，专注于开发癌症和皮肤病创新疗法。该公司在纳斯达克上市，股票代码为 PVCT。